StockNews.com Begins Coverage on Aethlon Medical (NASDAQ:AEMD)

StockNews.com assumed coverage on shares of Aethlon Medical (NASDAQ:AEMD) in a report published on Wednesday morning. The firm issued a sell rating on the medical equipment provider’s stock.

Separately, HC Wainwright dropped their target price on Aethlon Medical from $23.00 to $10.00 and set a buy rating for the company in a research note on Monday, March 4th.

Aethlon Medical Stock Performance

Shares of AEMD stock opened at $0.42 on Wednesday. The stock has a fifty day moving average price of $1.33 and a 200 day moving average price of $1.66. The stock has a market cap of $1.10 million, a PE ratio of -0.08 and a beta of 1.95. Aethlon Medical has a 1 year low of $0.37 and a 1 year high of $5.00.

Aethlon Medical Company Profile

Aethlon Medical, Inc, a medical therapeutic company, focuses on developing products to treat cancer and life-threatening infectious diseases in the United States. It develops Hemopurifier, a clinical-stage immunotherapeutic device that removes tumor-derived exosomes and life-threatening viruses and use in organ transplantation.